JPMorgan Chase & Co. and two other banks rejected a European Union deal to end an antitrust probe into the rigging of Euribor lending rates, risking higher fines and challenging the future of the EU’s settlement process.
OncoMed Pharmaceuticals Inc., a drug developer that first sold shares to the public in July, almost doubled in trading after signing a $177.25 million agreement with Celgene Corp. on as many as six potential cancer medicines.
President Barack Obama must name a Commodity Futures Trading Commission member with the experience needed to ward off Wall Street lobbying over the Volcker rule and speculation limits, nine Democratic senators said.
The top U.S. derivatives regulator is headed for a slowdown after the Senate panel responsible for confirming President Barack Obama’s picks for the Commodity Futures Trading Commission said it won’t act this year.
The furor over scrutiny of Tea Party groups by the Internal Revenue Service, which hurt President Barack Obama politically, has heightened difficulties for tax preparers dealing with the agency, according to a lawyer who specializes in tax-exemption issues.
Robins, Kaplan, Miller & Ciresi LLP bested Kellogg Huber Hansen Todd Evans & Figel PLLC in the arbitration between Starbucks Corp. and Mondelez International Inc. that resulted in a $2.79 billion victory for Mondelez.
Davis Polk & Wardwell LLP advised Shire Plc, which agreed to buy ViroPharma Inc. for about $4.2 billion to gain treatments for rare diseases and lessen dependence on its best-selling Vyvanse pill for attention deficit hyperactivity disorder. Skadden, Arps, Slate, Meagher & Flom LLP advised ViroPharma.